Grant D. Lawless, RPh, MD, FACP

Title(s)Associate Professor of Pharmaceutical & Health Economics (Teaching Track)
Address3335 S. Figueroa St
Off Campus
Los Angeles CA 90007
Phone+1 213 821 6181
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs. Per Med. 2018 07 01; 15(4):291-301. Oderda GM, Lawless GD, Wright GC, Nussbaum SR, Elder R, Kim K, Brixner DI. PMID: 29693487.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report. Am Health Drug Benefits. 2013 Jul; 6(5):236-46. AVBCC 2013 Steering Committee: Co-Chairs , Zweigenhaft B, Bosserman L, Kenney JT, Lawless GD, Marsland TA, Deligdish CK, Burgoyne DS, Knopf KB, Long DM, McKercher P, Owens GM, Hennessy JE, Lang JR, Malin J, Natelson L, Palmgren MC, Slotnik J, Shockney LD, Vogenberg FR. PMID: 24991360.
      View in: PubMed   Mentions:
    3. Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer. 2010 Jan 01; 116(1):193-202. Short LJ, Fisher MD, Wahl PM, Kelly MB, Lawless GD, White S, Rodriguez NA, Willey VJ, Brawley OW. PMID: 19877115.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    4. The working patient with cancer: implications for payers and employers. Am Health Drug Benefits. 2009 Jun; 2(4):168-73. Lawless GD. PMID: 25126288.
      View in: PubMed   Mentions:
    5. Impact of specialty drugs on the use of other medical services. Am J Manag Care. 2008 Dec; 14(12):821-8. Joyce GF, Goldman DP, Karaca-Mandic P, Lawless GD. PMID: 19067499.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    6. Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use. Am J Manag Care. 2008 Jul; 14(8 Suppl):S252-63. Willey VJ, Kopenski F, Lawless GD. PMID: 18672956.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Costs of severely ill members and specialty medication use in a commercially insured population. Health Aff (Millwood). 2008 May-Jun; 27(3):824-34. Willey VJ, Pollack MF, Lednar WM, Yang WN, Kennedy C, Lawless G. PMID: 18474976.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Current trends in pharmacy benefit designs: a threat to disease management in chronic complex diseases. Dis Manag. 2007 Apr; 10(2):74-82. Owens G, Emons MF, Christian-Herman J, Lawless G. PMID: 17444792.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Benefit design and specialty drug use. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1319-31. Goldman DP, Joyce GF, Lawless G, Crown WH, Willey V. PMID: 16966729.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    10. Chemotherapy dose intensity determination as a quality of care measure for managed care organizations in the treatment of early-stage breast cancer. Am J Med Qual. 2002 Nov-Dec; 17(6):218-24. Morrow T, Siegel M, Boone S, Lawless G, Carter W. PMID: 12487337.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Outpatient cancer drug costs: changes, drivers, and the future. Cancer. 2002 Feb 15; 94(4):1142-50. Halbert RJ, Zaher C, Wade S, Malin J, Lawless GD, Dubois RW. PMID: 11920485.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma. Oncology (Williston Park). 2001 Oct; 15(10):1296-306; discussion 1310-1, 1314. Picozzi VJ, Pohlman BL, Morrison VA, Lawless GD, Lee MW, Kerr RO, Ford JM, Delgado DJ, Fridman M, Carter WB. PMID: 11702959.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care. Cancer. 2001 Sep 15; 92(6):1354-67. Link BK, Budd GT, Scott S, Dickman E, Paul D, Lawless G, Lee MW, Fridman M, Ford J, Carter WB, Oncology Practice Pattern Study Working Group . PMID: 11745211.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    14. The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis. Clin Lymphoma. 2001 Jun; 2(1):47-56. Morrison VA, Picozzi V, Scott S, Pohlman B, Dickman E, Lee M, Lawless G, Kerr R, Caggiano V, Delgado D, Fridman M, Ford J, Carter WB, Oncology Practice Pattern Study Working Group . PMID: 11707870.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    15. A managed care approach to outpatient review. Qual Assur Util Rev. 1990 May; 5(2):53-7. Lawless GD. PMID: 2136665.
      View in: PubMed   Mentions:    Fields:    
    16. Cost containment through outpatient substance abuse services. Empl Benefits J. 1990 Mar; 15(1):6-10. Lawless GD. PMID: 10170526.
      View in: PubMed   Mentions:
    Grant's Networks
    Concepts (101)
    Derived automatically from this person's publications.
    Co-Authors (2)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department